Roy Mano - Concepedia

Author

Roy Mano

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

Brian Lane, Mano, Roy, R Mano, R. K. F. MANO, R. Mano, R. Rodríguez de la Mano, R., Mano, Roy Mano, Roy Mano*, Y Cheng

242

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Tel Aviv University Rabin Medical Center Tel Aviv Sourasky Medical Center Cornell University

About

Roy Mano is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, urology, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	32	1.5K
2	Public Health	3	3	66
3	Education	1	1	27
4	Anatomy	1	1	21
5	Child Development	1	1	27

Roy Mano

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Prognostic Factors and Risk Groups in T1G3 Non–Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients Paolo Gontero, Richard Sylvester, Francesca Pisano, European Urology Prognostic FactorsUrological ResearchUrologyBacillus Calmette-guérinUrologic Cancer Epidemiology	2014	241
Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study Alejandro Sánchez, Helena Furberg, Fengshen Kuo, The Lancet Oncology ObesityTranscriptomic SignaturesObesity ParadoxUrologyGenitourinary Cancer	2019	166
TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype A. Ari Hakimi, Satish K. Tickoo, Judy Sarungbam, Modern Pathology UrologyGenitourinary CancerTumor HeterogeneityRenal PathologyPathology	2015	163
The impact of re‐transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high‐grade/Grade 3 bladder cancer treated with bacille Calmette–Guérin Paolo Gontero, Richard Sylvester, Francesca Pisano, British Journal of Urology	2015	150
The impact of genetic heterogeneity on biomarker development in kidney cancer assessed by multiregional sampling Alexander Sankin, A. Ari Hakimi, Nina Mikkilineni, Cancer Medicine	2014	125
Ureteric stent dwelling time: a risk factor for post‐ureteroscopy sepsis Amihay Nevo, Roy Mano, Jack Baniel, British Journal of Urology	2017	111
Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non–muscle-invasive bladder cancer Roy Mano, Jack Baniel, Ohad Shoshany, Urologic Oncology Seminars and Original Investigations UrologyCancer ImmunosurveillanceGenitourinary CancerMedicinePathology	2014	110
Predictors of cancer‐specific mortality after disease recurrence following radical cystectomy Michael Rink, Daniel J. Lee, Matthew Kent, British Journal of Urology	2012	85
Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression Julian Marcon, Renzo G. DiNatale, Alejandro Sánchez, Clinical Cancer Research	2020	52
Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical Course Renzo G. DiNatale, Alexander N. Gorelick, Vladimir Makarov, European Urology Focus UrologyGenitourinary CancerMedicineRenal PathologyPathology	2019	49

Page 1